Active ingredientVogliboseCat. No. P-V058-001CAS 83480-29-9Family · Pharmaceutical analytical standards
Voglibose
An intestinal alpha-glucosidase inhibitor born in Japan: it slows down the digestion of sugars and blunts blood glucose peaks after meals in type 2 diabetes. It is one of only three medicines of this class used in clinical practice. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It derives from valiolamine, an amino pseudo-sugar first isolated in 1984 from the fermentation broth of a bacterium, Streptomyces hygroscopicus subsp. limoneus.
Go to the active ingredient →Active ingredientVogliboseCat. No. P-V058-001CAS 83480-29-9
Isotopically labelledVoglibose-13C3Cat. No. P-V058-002
Impurity(R)-Valiolamine VogliboseCat. No. P-V058-003CAS 1303996-67-9
Impurity(S)-Valiolamine VogliboseCat. No. P-V058-004CAS 1303996-66-8
Impurity1R-VogliboseCat. No. P-V058-005
Impurity2-Epi-ValioloneCat. No. P-V058-006CAS 1384518-63-1
ImpurityN-Methyl beta-D-GlucosylamineCat. No. P-V058-007CAS 114761-39-6
ImpurityValiolamineCat. No. P-V058-008CAS 83465-22-9
ImpurityValioloneCat. No. P-V058-009CAS 244230-63-5
ImpurityVoglibose Impurity 1Cat. No. P-V058-010
ImpurityVoglibose Impurity 2Cat. No. P-V058-011
ImpurityVoglibose Impurity 3Cat. No. P-V058-012
ImpurityVoglibose Impurity 4Cat. No. P-V058-013
ImpurityVoglibose Impurity 5Cat. No. P-V058-014
ImpurityVoglibose Impurity 6Cat. No. P-V058-015CAS 756527-27-2
ImpurityVoglibose Impurity 7Cat. No. P-V058-016CAS 756527-26-1
ImpurityVoglibose Impurity 8Cat. No. P-V058-017CAS 756527-25-0
ImpurityVoglibose Impurity 9Cat. No. P-V058-018CAS 679391-81-2
ImpurityVoglibose N-OxideCat. No. P-V058-019No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.